Tumour necrosis factor inhibition causing psoriasis? A more plausible explanation exists

Comment

J D Carter. Ann Rheum Dis. 2006 Dec.

. 2006 Dec;65(12):1680.

doi: 10.1136/ard.2006.054833.

No abstract available

Conflict of interest statement

Competing interests: None declared.

A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.
Ritchlin C, Tausk F. Ritchlin C, et al. Ann Rheum Dis. 2006 Dec;65(12):1541-4. doi: 10.1136/ard.2006.059261. Ann Rheum Dis. 2006. PMID: 17105851 Free PMC article. No abstract available.

New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.
Kary S, Worm M, Audring H, Huscher D, Renelt M, Sörensen H, Ständer E, Maass U, Lee H, Sterry W, Burmester GR. Kary S, et al. Ann Rheum Dis. 2006 Mar;65(3):405-7. doi: 10.1136/ard.2005.037424. Epub 2005 Sep 8. Ann Rheum Dis. 2006. PMID: 16150791 Free PMC article.

1. Kary S, Worm W, Audring H, Huscher D, Renelt M, Soerensen H.et al New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis 200665405–407. - PMC - PubMed
1. Sfikakis P P, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti‐tumor necrosis factor therapy. Arthritis Rheum 2005522513–2518. - PubMed
1. Schneider J M, Matthews J H, Graham B S. Reiter's syndrome. Cutis 200371198–200. - PubMed
1. Lee D A, Barker S M, Su W P D, Allen G L, Liesegang T J, Ilstrup D M. The clinical diagnosis of Reiter's syndrome: ophthalmic and nonophthalmic aspects. Ophthalmology 198693350–356. - PubMed
1. Montgomery M M, Poske R M, Barton E M, Foxworthy D T, Baker L A. The mucocutaneous lesions of Reiter's syndrome. Ann Intern Med 19595199–109. - PubMed